Evidence map›Paper›PMID 40475211›Full record

ArticleCochrane evidence synthesis and methods2023

The equity group: Supporting Cochrane's social responsibility of improving health equity.

Roses Parker, Jennifer Petkovic, Jordi Pardo Pardo, Andrea Darzi, Omar Dewidar, Joanne Khabsa, Elizabeth Kristjansson, Tamara Lotfi, Olivia Magwood, Lawrence Mbuagbaw and 6 more

Abstract read
In one paragraph

Article in Cochrane evidence synthesis and methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Roses ParkerThe Cochrane Collaboration London UK.ORCID 0000-0001-8156-5254
Jennifer PetkovicBruyère Research Institute and University of Ottawa Ottawa Ontario Canada.ORCID 0000-0002-5824-584X
Jordi Pardo PardoDepartment of Medicine, Faculty of Medicine University of Ottawa Ottawa Ontario Canada.
Andrea DarziDepartment of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada.
Omar DewidarBruyère Research Institute and University of Ottawa Ottawa Ontario Canada.
Joanne KhabsaClinical Research Institute American University of Beirut Medical Center Beirut Lebanon.
Elizabeth KristjanssonSchool of Psychology, Faculty of Social Sciences University of Ottawa Ottawa Ontario Canada.
Tamara LotfiDepartment of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada.
Olivia MagwoodBruyère Research Institute Ottawa Ontario Canada.
Lawrence MbuagbawDepartment of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada.
Kevin PottieDepartments of Family Medicine, Epidemiology and Biostatistics Western University London Ontario Canada.
Alison RiddleBruyère Research Institute and University of Ottawa Ottawa Ontario Canada.
Ammar SaadSchool of Epidemiology and Public Health University of Ottawa Ottawa Ontario Canada.
Eve TomlinsonPopulation Health Sciences, Bristol Medical School University of Bristol Bristol UK.
Peter TugwellDepartment of Medicine, Faculty of Medicine University of Ottawa Ottawa Ontario Canada.
Vivian WelchDepartment of Anesthesia, Faculty of Health Sciences McMaster University Hamilton Ontario Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Health equity is a moral and ethical imperative for clinicians, researchers, policymakers, and all who use health research. Both Cochrane and the Campbell Collaboration have focused on health equity for many years. Methods: The new Equity Group will continue and expand this work by designing a program of projects aiming to (1) promote equity in the evidence base, (2) ensure equitable processes for stakeholder engagement, (3) produce high-priority, equity-focused evidence syntheses, (4) build capacity for equity design, analysis, and reporting, and (5) promote equity in implementation tools. Results: We will build on our current network of collaborators and create a group structure striving to recruit across the PROGRESS-Plus characteristics. Conclusion: We invite readers to join our cause and contribute wherever they are able. Together, we can help Cochrane achieve its social responsibility of improving health equity at a planetary level.

Indexed as

diversity and inclusionevidence synthesishealth equityPROGRESS‐Plussocial determinants of healthstakeholder engagementsystematic reviews

Identifiers

PMID40475211
PMCPMC11795894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.